Truck travel time prediction is the basis for real-time optimal scheduling decision of open-pit trucks. Most prediction models for open-pit truck travel time mainly rely on a single machine learning algorithm or model to optimize the hyperparameters, which is difficult to accurately capture the composite characteristics of truck travel time data, affectting the accuracy of the prediction results. This paper proposed a travel time prediction method for open-pit trucks based on LSTM-TabTransformer. After eliminating the outliers in the truck travel time data set by applying the Paura criterion, the data set was non-dimensionalized, and the corresponding category data was processed by means of data diversion. Then, the self-attention mechanism of TabTransformer and gating mechanism of LSTM were used to capture the dynamic characteristics of the travel time variation rule at multiple levels. Finally, the dimensionality of the concatenated feature matrix was reduced by MLP, and the predicted truck travel time was output. Based on the truck travel time series data set collected from the example open-pit coal mine, the prediction experiment was carried out. The results show that the combined machine learning model LSTM-Tabtransformer proposed in this paper is suitable to process the complex truck travel time series data set and learn multiple features, which can reduce the volatility of relative absolute error (RAE) and relative square error (RSE) of travel time prediction, overcome the limitations of a single machine learning prediction model, effectively increase the sensitivity of learning features, and significantly improve the accuracy of truck travel time prediction in open-pit mines.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11876564 | PMC |
http://dx.doi.org/10.1038/s41598-025-88543-x | DOI Listing |
Int J Health Plann Manage
March 2025
Division of Socio-Behavioural, Health Systems & Implementation Research, Indian Council of Medical Research, New Delhi, India.
This study addresses significant healthcare access challenges faced by India's 104 million-strong tribal population, who are among the most disadvantaged and typically live in hilly rural and remote areas with poor health infrastructure and resources. The study aims to examine healthcare access patterns in six tribal areas, focussing on primary health centres (PHCs), to develop a strategy that improves healthcare service accessibility, quality, and utilization for tribal communities. Data were collected from 9837 participants from 24 PHC areas across six states.
View Article and Find Full Text PDFBreast Cancer Res
March 2025
Centre for Experimental Cancer Medicine, Barts Cancer Institute, London, UK.
Background: The multicohort, open-label, phase 1b KEYNOTE-173 study was conducted to investigate pembrolizumab plus chemotherapy as neoadjuvant therapy for triple-negative breast cancer (TNBC). This exploratory analysis evaluated features of the tumor microenvironment that might be predictive of response.
Methods: Cell fractions from 20 paired samples collected at baseline and after one cycle of neoadjuvant pembrolizumab prior to chemotherapy initiation were analyzed by spatial localization (tumor compartment, stromal compartment, or sum of tumor and stromal compartments [total tumor]) using three six-plex immunohistochemistry panels with T-cell, myeloid cell, and natural killer cell components.
BMC Psychiatry
March 2025
Teva Branded Pharmaceutical Products R&D, Inc., North America Medical Affairs, Parsippany, NJ, USA.
Background: Long-acting injectable antipsychotics (LAIs) reduce relapses in schizophrenia; however, most clinicians reserve LAIs for nonadherence with oral antipsychotics (OAs) or severe disease.
Methods: US psychiatric clinicians were surveyed regarding their schizophrenia management practices and use of LAIs. Respondents were grouped by LAI use (high [≥ 31% of patients using LAIs], low [≤ 14% using LAIs]; mid not analyzed) and mindset based on their response to "Which of the following best fits the current way you view your use of [LAIs] for your patients with schizophrenia?"
Results: Respondents (n = 380) were distributed across LAI use (106 high, 130 low) and mindset (123 early-use, 88 severity-reserved, 113 adherence-reserved, 56 LAI-hesitant) subgroups.
BMC Cancer
March 2025
Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Background: Atezolizumab plus bevacizumab is recommended as a first-line treatment for unresectable hepatocellular carcinoma (uHCC). A subgroup analysis of the IMbrave150 trial showed shorter overall survival (OS) in uHCC patients with stable disease (SD) than patients with complete response (CR) or partial response (PR) after atezolizumab plus bevacizumab. Improving OS in patients with SD is an unmet medical need.
View Article and Find Full Text PDFRural Remote Health
March 2025
Warm Corners Consulting, Orbost, Vic. 3888, Australia.
Introduction: Australians living in isolated communities are more likely to experience poorer health outcomes as a result of rurality. This article provides a needs assessment of healthcare services in a geographically isolated region of Victoria, Australia.
Methods: The research project employed a mixed-methods design.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!